Battaini F, Pascale A, Lucchi L, Pasinetti G M, Govoni S
Department of Neurosciences, University of Roma Tor Vergata, Rome, Italy.
Exp Neurol. 1999 Oct;159(2):559-64. doi: 10.1006/exnr.1999.7151.
Protein kinase C (PKC) has been implicated in the pathophysiology of Alzheimer's disease (AD). The levels of particular isoforms and the activation of PKC are reduced in postmortem brain cortex of AD subjects. Receptors for activated C kinase (RACK) are a family of proteins involved in anchoring activated PKCs to relevant subcellular compartments. Recent evidence has indicated that the impaired activation (translocation) of PKC in the aging brain is associated with a deficit in RACK1, the most well-characterized member of this family. The present study was conducted to determine whether alterations in RACK1 occurred in cortical areas where an impaired translocation of PKC has been demonstrated in AD. Here we report the presence of RACK1 immunoreactivity in human brain frontal cortex for the first time and demonstrate a decrease in RACK1 content in cytosol and membrane extracts in AD when compared with non-AD controls. By comparison, the levels of the RACK1-related PKCbetaII were not modified in the same membrane extracts. These observations add a new perspective in understanding the disease-associated defective PKC signal transduction and indicate that a decrease in an anchoring protein for PKC is an additional determinant of this deficit.
蛋白激酶C(PKC)与阿尔茨海默病(AD)的病理生理学有关。在AD患者死后的脑皮质中,特定亚型的水平及PKC的活性降低。活化C激酶受体(RACK)是一类参与将活化的PKC锚定到相关亚细胞区室的蛋白质家族。最近的证据表明,衰老大脑中PKC活化(易位)受损与该家族中特征最明确的成员RACK1的缺陷有关。本研究旨在确定在AD中已证实PKC易位受损的皮质区域是否发生RACK1的改变。在此,我们首次报道了RACK1免疫反应性在人类脑额叶皮质中的存在,并证明与非AD对照相比,AD患者胞质溶胶和膜提取物中的RACK1含量降低。相比之下,在相同的膜提取物中,与RACK1相关的PKCβII水平未发生改变。这些观察结果为理解与疾病相关的PKC信号转导缺陷增添了新的视角,并表明PKC锚定蛋白的减少是这种缺陷的另一个决定因素。